Evidence map›Paper›PMID 42515024›Full record

ReviewPathogens (Basel, Switzerland)2026

Changing Patterns in Infective Endocarditis: A Contemporary Epidemiological Perspective.

Vasiliki Rapti, Anna-Pelagia Magiorakos, Efthymia Giannitsioti, Garyfallia Poulakou

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Vasiliki RaptiThird Department of Internal Medicine and Laboratory, School of Medicine, National & Kapodistrian University of Athens, Sotiria General Hospital, 115 27 Athens, Greece.ORCID 0000-0002-8322-635X
Anna-Pelagia MagiorakosIndependent Researcher, 115 27 Athens, Greece.
Efthymia GiannitsiotiFirst Department of Propaedeutic and Internal Medicine, School of Medicine, National & Kapodistrian University of Athens, Laiko General Hospital, 115 27 Athens, Greece.ORCID 0000-0003-2715-7457
Garyfallia PoulakouThird Department of Internal Medicine and Laboratory, School of Medicine, National & Kapodistrian University of Athens, Sotiria General Hospital, 115 27 Athens, Greece.ORCID 0000-0003-0778-0006

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since its first description in the late nineteenth century, the epidemiology of infective endocarditis (IE) has changed considerably. Once primarily affecting younger individuals with structural heart disease, IE is now increasingly encountered in older patients with multiple comorbidities and frequent healthcare exposure. Population ageing, end-stage renal disease (ESRD), immunosuppression, and injection drug use (IDU) have broadened the pool of susceptible hosts. At the same time, the increasing use of prosthetic valves (PVs), cardiac implantable electronic devices (CIEDs), and transcatheter cardiac interventions has reshaped the clinical spectrum of IE. This epidemiological transition has also been accompanied by shifts in microbiological patterns, with a growing predominance of staphylococci and enterococci, as well as marked geographic and socioeconomic variation in disease burden. This review summarizes the contemporary epidemiology of IE, with an emphasis on the host-, healthcare-, and microbiological factors underlying its evolving clinical profile.

Indexed as

EndocarditisEndocarditis, BacterialHumansProsthesis-Related InfectionsRisk Factorsageing populationcardiac implantable electronic device infectionchronic kidney diseaseepidemiologyhealthcare-associated infectioninfective endocarditisinjection drug useprosthetic valve endocarditisStaphylococcus aureustranscatheter aortic valve replacement

Identifiers

PMID42515024
PMCPMC13414730

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.